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This translocation with IRTA1 involvement is different 
from t(1;14)(q21;q32) with BCL9 involvement, from 
the t(1;14)(q21;q32) with FCGR2B involvement, and 
from the t(1;14)(q21;q32) with MUC1 involvement. 
Clinics and pathology 
Disease 
Multiple Myeloma and B-cell non-Hodgkins 
lymphoma. 
Epidemiology 
Rare. 2 published cases: 1 in a multiple myeloma cell 






The t(1;14) interrupts the IRTA gene locus 
(Immunoglobulin superfamily Receptor Translocation 
Associated gene locus) which spans approximately 
250kb, between the IRTA1 and IRTA2 genes. 







IRTA1 localises to the IRTA gene locus. Three IRTA1 
transcripts of 2.5kb, 2.7kb and 3.5kb are possible du
to alternate usage of 3 polyadenylation sites. 
Protein 
The three alternate IRTA1 transcripts give rise to the
same putative 515 amino acid protein.  
The protein shows a signal peptide, four extracellular 
Ig-type domains carrying three potential asparagaine 
(N)-linked glycosylation sites, a 16 amino acid 
transmmbrane and a 106 amino acid cytoplasmic 
domain with three putative consensus Src-homology 2 
SH2 binding domains.  
These domains show similarity to both ITAM 
(Immunoreceptor Tyrosine-based Activation Motifs) 
and ITIM (Immunoreceptor Tyrosine-based Inhibition 
Motifs). The function of the protein is unknown.  
It is expressed in marginal zone B cells. In the 
extracellular domain IRTA1 protein shows homology 
to Ig superfamily receptors (47% identity and 51% 
similarity) and Fc receptor family (37% identity and 
50% similarity). In the intracellular domain, IRTA1 
shows striking homology to PECAM1 (31% identity 








Expression of IRTA1 fusion proteins. In the first case  
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described the t(1;14) juxtaposes the IRTA1 gene to the 
C alpha constant gene in the same transcriptional 
orientation on the der(14) chromosome. An IRTA1/C 
alpha fusion protein results from this. The predicted 
fusion protein fuses the signal peptide and first two 
extracellular residues of IRTA1 to the C alpha encoded 
transmembrane and cytoplasmic domains. 
Overexpression of IRTA1 was not observed in other 
myeloma or lymphoma cell lines, regardless of the 
status of its chromosomal band 1q21. 
More recently long distance inverse PCR cloning 
identified a second case of IRTA1 translocation to IGH 
switch sequence (Switch gamma 3) in a case of gastric 
DLBCL. 
In contrast, IRTA2 gene (located telomeric of IRTA1 
in the IRTA gene locus) shows frequent deregulation in 
Burkitt lymphoma and Multiple Myeloma cell lines 
with 1q21 abnormalities (mostly duplications or 
unbalanced translocations that lead to trisomy or 
tetrasomy 1q). 
IRTA1 is normally expressed in marginal zone B cells 
while IRTA2 is selectively expressed in centrocytes, 
marginal zone B cells and immunoblasts. 
IRTA1 and 2 have been independently cloned as 
FcRH4 and FcRH5 (Fc Receptor Homologues) from a 
human lymph node cDNA library. 
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